News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hutchison Medipharma Releases Phase I Data on Two Cancer Molecules


6/8/2012 9:28:17 AM

by Richard Daverman, PhD

June 7, 2012 -- Hutchison MediPharma, the innovative China drug company that is majority owned by Chi-Med, released positive Phase I data for its two most advanced cancer-targeting molecules: Sulfatinib (HMPL-012) and Fruquintinib (HMPL-013). Both drug candidates were well-tolerated and showed preliminary evidence of efficacy against multiple tumor types. More details....

Stock Symbol: (AIM: CHM)


Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES